Human natural fibroblast IFN-β, which belongs to the type I IFN family like IFN-α, is available for intravenous administration for the treatment of chronic hepatitis B and chronic hepatitis C in Japan. This evidence concerns the gene IFNB1 and chronic hepatitis C virus infection.